This study presents a cohort of individuals with heterozygous damaging variants in EIF3A and EIF3B, exhibiting a heterogeneous clinical phenotype primarily characterized by craniofacial abnormalities, CHD (most commonly TOF), and mild neurodevelopmental features. This evidence concerns the gene EIF3A and coronary artery disorder.